Unlock Financial Freedom: Charles Schwab’s Top Investing Tipsby Mark Eisenberg 10.08.2024Discover Charles Schwab's expert tips for long-term investing success, providing a roadmap to financial freedom and security.
Bitfarms Plans Growth Amid Revenue Declineby Mark Eisenberg 10.08.2024Bitfarms reports revenue drop but eyes growth in HPC/AI with $195M liquidity.
WSFS Financial’s Debt Ratings Affirmed by KBRAby Mark Eisenberg 10.08.2024WSFS Financial's strong ratings affirmed by KBRA, highlighting stability in earnings, liquidity, and diversified income.
Mercer Advisors Launches Aspen Partners Platformby Mark Eisenberg 09.08.2024Mercer Advisors unveils Aspen Partners, a private-investments platform with low fees, expanding access to diversified private markets.
David Booth’s Dimensional and Passive Investing Concernsby Mark Eisenberg 09.08.2024David Booth's Dimensional Fund Advisors raises concerns about passive investing, prompting a reevaluation of investment strategies.
Investors Seize Tech Stock Bargains Amid Market Plungeby Mark Eisenberg 09.08.2024Tech stocks rebound as investors capitalize on market downturn, finding rare opportunities in AI and chip sectors.
Paramount Global Surges 5% Despite Revenue Missby Mark Eisenberg 09.08.2024Paramount Global beats Q2 earnings expectations; stock rises 5.4% amidst revenue shortfall in challenging media market.
Blue Owl Capital’s Strong Quarter & Merger Plansby Mark Eisenberg 09.08.2024Blue Owl Capital reports strong Q2 2024 earnings and plans merger with OBDE to enhance scale and liquidity.
Commerzbank Targets 2024 Growth Amid Challengesby Mark Eisenberg 09.08.2024Commerzbank maintains 2024 goals despite Q2 challenges, plans €1.6B capital return. Solid loan demand and strategic investments.
Top 3 Biotech Stocks to Buy for August 2024by Lilu Anderson 08.08.2024Explore promising biotech stocks like Vertex, Pfizer, and Merck, ready to innovate and grow in the evolving healthcare landscape.